EYAL TALOR
CIK 1238028 · Chief Scientific Officer · last filed 2026-04-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.6K
Companies
2
Total Filings
109
Lifetime Open-Market Net
-$355.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVM | Chief Scientific Officer | 7,011 | $1.08 | $7.6K | -$296.8K | 80 | 2026-04-01 |
| CEL SCI CORP (CVM.WS) Delisted | Chief Scientific Officer | 116,159 | — | — | -$58.9K | 29 | 2018-10-01 |
Recent Filings · Page 3 of 11
109 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-31 | CVM | Grant (A) | +610 | $2.4K | EDGAR |
| 2022-01-03 | CVM | Grant (A) | +338 | $2.4K | EDGAR |
| 2021-11-29 | CVM | Grant (A) | — | $0 | EDGAR |
| 2021-10-21 | CVM | Sell (S) | −15,000 | -$168.8K | EDGAR |
| 2021-10-04 | CVM | Grant (A) | +218 | $2.4K | EDGAR |
| 2021-07-01 | CVM | Grant (A) | +276 | $2.4K | EDGAR |
| 2021-05-17 | CVM | Grant (A) | — | $0 | EDGAR |
| 2021-04-01 | CVM | Grant (A) | +157 | $2.4K | EDGAR |
| 2021-01-04 | CVM | Grant (A) | +205 | $2.4K | EDGAR |
| 2020-10-01 | CVM | Grant (A) | +188 | $2.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.